About
Stephen Rapecki originated the blockbuster biologic bimekizumab from discovery to approval, combining 30 years of hands-on drug discovery at Celltech/UCB with ongoing peer-reviewed immunology research and seed-stage cofounding and advising.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- MedicxiVenture Partnercurrent2023 β presentLondon, England, United Kingdom
- UCBDirector, Experimental Therapeutics2019 β 2023
- UCBHead Of Rationally Designed NBEs2018 β 2023Slough, United Kingdom
- UCBDirector Functional Screening2017 β 2023Slough, United Kingdom
- UCBSenior Group Leader2015 β 2017Slough, United Kingdom
- UCBSenior Principle Scientist2007 β 2015
- Celltech PharmaceuticalsSenior Scientist1993 β 2007Slough, United Kingdom
Skills & more
Start-up Ventures3Early Stage Investment2Immunology11Drug Discovery13Cell Culture4Pharmacology7Clinical Development2Biopharmaceuticals6Biochemistry3Biomarkers2Drug Development5Molecular Biology3
+11 more
Monoclonal AntibodiesAssay DevelopmentAntibodiesLife SciencesBiotechnologyCell BiologyR&DCellPharmaceutical IndustryELISAIn VitroFrom Stephen's professional profile.
Colleagues at Medicxi
Frequently asked questions
- Who is Stephen Rapecki?
- Stephen Rapecki originated the blockbuster biologic bimekizumab from discovery to approval, combining 30 years of hands-on drug discovery at Celltech/UCB with ongoing peer-reviewed immunology research and seed-stage cofounding and advising.
- Where does Stephen Rapecki work?
- Stephen Rapecki is Venture Partner at Medicxi.
- What does Stephen Rapecki invest in?
- Stephen Rapecki invests in Biotech, Digital Health, Healthtech, Medical Devices.
- Where did Stephen Rapecki go to school?
- Stephen Rapecki studied at Kingston University (Bachelor of Science - BS, Biomedical Sciences); Lewis Boys School.
Same school
Also attended Kingston University28
Matthew KnowlesOperating Partner at TempoCapRenΓ© RechtmanInvestor at FELIX CAPITALMaria Henriques da SilvaMarketing & Brand Lead at Shilling VCHelen ClarkPartner at Piton Capital LLPAnil HansjeeGeneral Partner at Fabric VenturesRadhika KhemkaSenior Manager at Anicut Capital
+ 22 more





















